+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Ophthalmology Drugs and Devices Market 2019-2027

  • ID: 4827802
  • Report
  • Region: Global
  • 210 pages
  • Triton Market Research
1 of 3

FEATURED COMPANIES

  • Allergan, Inc.
  • Bayer
  • Carl Zeiss AG
  • Glaxosmithkline
  • Johnson & Johnson, Inc.
  • Novartis International AG
  • MORE
Market Outlook

The author predicts that the global market for ophthalmology drugs and devices is set to witness a CAGR of 6.16% over the forecast period 2019-2027. The global ophthalmology drugs and devices market is primarily driven by the rising prevalence of eye-related diseases as well as the innovation leading to the development of new ophthalmological drugs. Ophthalmic devices and drugs are used in the treatment and identification of certain ocular malformations and deficits in the eyes. Factors like growth in the elderly populace, increasing ophthalmic disorders caused by high blood sugar, upsurge in healthcare expenditure and advancements in technology are driving the ophthalmology drugs and devices market. Whereas, drug approval delay, coupled with several drugs in the pipeline, low awareness of ophthalmic drugs and brand patent expirations have affected the pharmaceutical industry, thus restraining the market growth. Rising opportunities for ophthalmic drugs in developing countries and the demand for intraocular lenses and phacoemulsification devices provide further support to the market growth. However, risks associated with the treatment of ocular diseases are creating challenges for the growth of the ophthalmology drugs and devices market.

Regional Outlook
The Asia-Pacific, Latin America, Europe, North America and the Middle East and Africa are the regions that form the global ophthalmology drugs and devices market. North America is the market leader for ophthalmic drugs and devices market, worldwide. The ophthalmology drugs and devices market in North America is driven primarily due to the high healthcare and R&D expenditure in the US and Canada, coupled with the high prevalence of eye diseases in the region. Such high spending on healthcare, coupled with demand for quality healthcare, asserts the adoption of novel healthcare ailments, thus, positively supplementing the ophthalmology drugs and devices market growth. Furthermore, government investment to support eye research also drives the ophthalmology drugs and devices market in the North American region.

Competitive Outlook
The top companies that have been studied in the ophthalmic drugs and devices market are Ziemer Group Holding AG, Valeant Pharmaceuticals International, Inc., Sun Pharmaceuticals Industries, Ltd., Santen Pharmaceutical Co., Ltd., Roche Holding AG, Pfizer, Novartis International AG, Johnson & Johnson, Inc., GlaxoSmithKline, Essilor International S.A., Carl Zeiss AG, Bayer and Allergan, Inc.

Essilor International S.A. is a France-based company engaged in the designing, manufacturing and production of ophthalmic lenses as well as ophthalmic optical equipment. The company operates its business in North America, Latin America, Europe, Asia/Oceania and Africa. At the end of 2016, Essilor International achieved revenues of $ 8.80 billion and employed around 64,000 employees across the globe. Transitions VI lenses, Varilux, Crizal and Xperio UV are some of the company’s prime products. In May 2015, Essilor International S.A. acquired a 37% stake in GKB Ophthalmics’ lens with $3.6 billion. The acquisition strategy was aimed to help in growing the company’s market presence and geographical presence to capture more market share.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Allergan, Inc.
  • Bayer
  • Carl Zeiss AG
  • Glaxosmithkline
  • Johnson & Johnson, Inc.
  • Novartis International AG
  • MORE
1. Global Ophthalmology Drugs and Devices Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Analysis
2.2.1. Bargaining Power of Buyers
2.2.2. Bargaining Power of Supplier
2.2.3. Threats of New Entrants
2.2.4. Threats of Substitutes
2.2.5. Competitive Rivalry
2.3. Strategic Outlook
2.4. Market Share Outlook
2.5. Key Insight
2.6. Value Chain Outlook
2.7. Key Buying Standards
2.8. Investment Outlook
2.9. Supply Chain Outlook
2.10. Regulatory Framework
2.11. Market Drivers
2.11.1. Elderly Population Is Increasing Worldwide
2.11.2. Increasing Ophthalmic Disorders Due to High Blood Sugar
2.11.3. Upsurge in Healthcare Spending
2.11.4. Technological Advancement
2.12. Market Restraints
2.12.1. Expirations of Brand Patents Have Affected the Pharmaceutical Industry
2.12.2. Low Cognizance Related to Ophthalmic Drugs
2.12.3. Drug Approvals Delay and Number of Drugs in the Pipeline
2.13. Market Opportunities
2.13.1. Increasing Demand for Phacoemulsification Devices and Intraocular Lenses
2.13.2. Rising Opportunities in the Developing Countries
2.14. Market Challenges
2.14.1. Difficulties Associated With the Conduct of Ocular Diseases

3. Opthalmology Drugs and Devices Market Outlook - by Drugs and Devices
3.1. Devices
3.1.1. Diagnostic & Monitoring Equipment
3.1.1.1. Optical Coherence Tomography
3.1.1.2. Ophthalmic Ultrasound Imaging Systems
3.1.1.3. Fundus Camera Market
3.1.1.4. Ophthalmoscopes
3.1.1.5. Retinoscope
3.1.1.6. Pachymeter
3.1.1.7. Wavefront Aberrometers
3.1.1.8. Perimeters/Visual Field Analyzer
3.1.1.9. Autorefractors/Phoropter
3.1.1.10. Specular Microscope
3.1.1.11. Corneal Topographers
3.1.1.12. Other Diagnostic & Monitoring Equipment Market
3.1.2. Surgery Device
3.1.2.1. Cataract Surgery Devices
3.1.2.2. Glaucoma Surgery Devices
3.1.2.3. Refractive Surgery Devices
3.1.2.4. Vitreoretinal Surgery Devices
3.1.3. Vision Care
3.2. Drugs
3.2.1. Glaucoma Drug
3.2.2. Retinal Disorder Drug
3.2.3. Dry Eye Drug
3.2.4. Allergic Conjunctivitis, Inflammation and Conjunctivitis Drug
3.2.5. Drugs by Use of Preservation
3.2.5.1. Preserved Drugs
3.2.5.2. Preservative-Free Drugs

4. Opthalmology Drugs and Devices Market - Regional Outlook
4.1. North America
4.1.1. Market by Drugs and Devices
4.1.1.1. Market by Devices
4.1.1.2. Market by Drugs
4.1.2. Country Analysis
4.1.2.1. The United States
4.1.2.2. Canada
4.2. Europe
4.2.1. Market by Drugs and Devices
4.2.1.1. Market by Devices
4.2.1.2. Market by Drugs
4.2.2. Country Analysis
4.2.2.1. The United Kingdom
4.2.2.2. France
4.2.2.3. Germany
4.2.2.4. Spain
4.2.2.5. Italy
4.2.2.6. Russia
4.2.2.7. Rest of Europe
4.3. Asia-Pacific
4.3.1. Market by Drugs and Devices
4.3.1.1. Market by Devices
4.3.1.2. Market by Drugs
4.3.2. Country Analysis
4.3.2.1. India
4.3.2.2. China
4.3.2.3. Japan
4.3.2.4. South Korea
4.3.2.5. Australia & New Zealand
4.3.2.6. Asean Countries
4.3.2.7. Rest of Apac
4.4. Latin America
4.4.1. Market by Drugs and Devices
4.4.1.1. Market by Devices
4.4.1.2. Market by Drugs
4.4.2. Country Analysis
4.4.2.1. Brazil
4.4.2.2. Mexico
4.4.2.3. Rest of Latin America
4.5. Middle East and Africa
4.5.1. Market by Drugs and Devices
4.5.1.1. Market by Devices
4.5.1.2. Market by Drugs
4.5.2. Country Analysis
4.5.2.1. Saudi Arabia
4.5.2.2. Turkey
4.5.2.3. United Arab Emirates
4.5.2.4. South Africa
4.5.2.5. Rest of Middle East & Africa

5. Competitive Landscape
5.1. Allergan, Inc.
5.2. Bayer
5.3. Carl Zeiss AG
5.4. Essilor International S.A.
5.5. Glaxosmithkline
5.6. Johnson & Johnson, Inc.
5.7. Novartis International AG
5.8. Pfizer
5.9. Roche Holding AG
5.10. Santen Pharmaceutical Co., Ltd.
5.11. Sun Pharmaceuticals Industries, Ltd.
5.12. Valeant Pharmaceuticals International, Inc.
5.13. Ziemer Group Holding AG

6. Methodology and Scope
6.1. Research Scope
6.2. Sources of Data
6.3. Research Methodology

List of Tables
Table 1 Global Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Table 2 Common Causes of Loss of Vision in the Elderly
Table 3 Selected List of Glaucoma Drugs in Late-Stage Clinical Trials
Table 4 Eye Drugs Gone Off-Patent
Table 5 Global Ophthalmology Drugs and Devices Market by Drugs and Devices 2019-2027 ($ Million)
Table 6 Global Devices Market in Diagnostic & Monitoring Equipment by Types 2019-2027 ($ Million)
Table 7 Global Devices Market in Surgery Device by Types 2019-2027 ($ Million)
Table 8 Global Drugs and Devices Market in Drugs by Types 2019-2027 ($ Million)
Table 9 Global Drugs Market in Drugs by Use of Preservation 2019-2027 ($ Million)
Table 10 Global Drugs by Use of Preservation in Preservative Free Drugs by Doses 2019-2027 ($ Million)
Table 11 Global Drugs by Use of Preservation in Preservative-Free Drugs 2019-2027 ($ Million)
Table 12 Global Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Table 13 North America Ophthalmology Drugs and Devices Market by Drugs and Devices 2019-2027 ($ Million)
Table 14 North America Opthalmology Drugs and Devices Market by Countries 2019-2027 ($ Million)
Table 15 Europe Ophthalmology Drugs and Devices Market by Drugs and Devices 2019-2027 ($ Million)
Table 16 Europe Opthalmology Drugs and Devices Market by Countries 2019-2027 ($ Million)
Table 17 Asia-Pacific Ophthalmology Drugs and Devices Market by Drugs and Devices 2019-2027 ($ Million)
Table 18 Asia-Pacific Opthalmology Drugs and Devices Market by Countries 2019-2027 ($ Million)
Table 19 Latin America Ophthalmology Drugs and Devices Market by Drugs and Devices 2019-2027 ($ Million)
Table 20 Latin America Opthalmology Drugs and Devices Market by Countries 2019-2027 ($ Million)
Table 21 Middle East and Africa Ophthalmology Drugs and Devices Market by Drugs and Devices 2019-2027 ($ Million)
Table 22 Middle East and Africa Opthalmology Drugs and Devices Market by Countries 2019-2027 ($ Million)

List of Figures
Figure 1 Global Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 2 Global Ophthalmology Devices Company Market Share 2018 (%)
Figure 3 Global Ophthalmology Drugs Company Market Share 2018 (%)
Figure 4 The Population of People Aged 65 and Over Will Double in the Next 25 Years (In Million)
Figure 5 Projections for the Proportion of Geriatric (60+) Population in 2015, 2030 & 2050
Figure 6 Prevalence of Diabetes by Age Group (In Million)
Figure 7 Global Drugs and Devices Market in Devices 2019-2027 ($ Million)
Figure 8 Global Devices Market in Diagnostic & Monitoring Equipment 2019-2027 ($ Million)
Figure 9 Global Diagnostic & Monitoring Equipment Market in Optical Coherence Tomography 2019-2027 ($ Million)
Figure 10 Global Diagnostic & Monitoring Equipment Market in Ophthalmic Ultrasound Imaging Systems 2019-2027 ($ Million)
Figure 11 Global Diagnostic & Monitoring Equipment Market in Fundus Camera Market 2019-2027 ($ Million)
Figure 12 Global Diagnostic & Monitoring Equipment Market in Ophthalmoscopes 2019-2027 ($ Million)
Figure 13 Global Diagnostic & Monitoring Equipment Market in Retinoscope 2019-2027 ($ Million)
Figure 14 Global Diagnostic & Monitoring Equipment Market in Pachymeter 2019-2027 ($ Million)
Figure 15 Global Diagnostic & Monitoring Equipment Market in Wavefront Aberrometers 2019-2027 ($ Million)
Figure 16 Global Diagnostic & Monitoring Equipment Market in Perimeters/Visual Field Analyzer 2019-2027 ($ Million)
Figure 17 Global Diagnostic & Monitoring Equipment Market in Autorefractors/Phoropter 2019-2027 ($ Million)
Figure 18 Global Diagnostic & Monitoring Equipment Market in Specular Microscope 2019-2027 ($ Million)
Figure 19 Global Diagnostic & Monitoring Equipment Market in Corneal Topographers 2019-2027 ($ Million)
Figure 20 Global Diagnostic & Monitoring Equipment Market in Other Diagnostic & Monitoring Equipment Market 2019-2027 ($ Million)
Figure 21 Global Devices Market in Surgery Device 2019-2027 ($ Million)
Figure 22 Global Surgery Devices Market in Cataract Surgery Devices 2019-2027 ($ Million)
Figure 23 Global Surgery Devices Market in Glaucoma Surgery Devices 2019-2027 ($ Million)
Figure 24 Global Surgery Devices Market in Refractive Surgery Devices 2019-2027 ($ Million)
Figure 25 Global Surgery Devices Market in Vitreoretinal Surgery Devices 2019-2027 ($ Million)
Figure 26 Global Devices Market in Vision Care Market 2019-2027 ($ Million)
Figure 27 Global Drugs and Devices Market in Drugs 2019-2027 ($ Million)
Figure 28 Global Drugs Market in Glaucoma Drug 2019-2027 ($ Million)
Figure 29 Global Drugs Market in Retinal Disorder Drug 2019-2027 ($ Million)
Figure 30 Global Drugs Market in Dry Eye Drug 2019-2027 ($ Million)
Figure 31 Global Drugs Market in Allergic Conjunctivitis, Inflammation and Conjunctivitis Drug 2019-2027 ($ Million)
Figure 32 Global Drugs by Use of Preservation in Preserved Drugs 2019-2027 ($ Million)
Figure 33 Global Drugs by Use of Preservation in Preservative-Free Drugs 2019-2027 ($ Million)
Figure 34 Global Preservative-Free Drugs Market in Single-Dose 2019-2027 ($ Million)
Figure 35 Global Preservative-Free Drugs Market in Multi-Dose 2019-2027 ($ Million)
Figure 36 North America Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 37 The United States Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 38 Canada Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 39 Europe Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 40 The United Kingdom Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 41 France Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 42 Germany Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 43 Spain Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 44 Italy Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 45 Russia Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 46 Rest of Europe Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 47 Asia-Pacific Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 48 India Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 49 China Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 50 Japan Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 51 South Korea Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 52 Australia & New Zealand Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 53 Asean Countries Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 54 Rest of Apac Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 55 Brazil Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 56 Mexico Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 57 Rest of Latin America Countries Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 58 Saudi Arabia Countries Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 59 Turkey Countries Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 60 The United Arab Emirates Countries Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 61 South Africa Countries Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 62 Rest of Middle East & Africa Countries Opthalmology Drugs and Devices Market 2019-2027 ($ Million)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Allergan, Inc.
  • Bayer
  • Carl Zeiss AG
  • Essilor International S.A.
  • Glaxosmithkline
  • Johnson & Johnson, Inc.
  • Novartis International AG
  • Pfizer
  • Roche Holding AG
  • Santen Pharmaceutical Co., Ltd.
  • Sun Pharmaceuticals Industries, Ltd.
  • Valeant Pharmaceuticals International, Inc.
  • Ziemer Group Holding AG
Note: Product cover images may vary from those shown
Adroll
adroll